The Future of Falsified and Substandard Medicine Detection: Digital Methods To Track and Authenticate Pharmaceutical Products

The Future of Falsified and Substandard Medicine Detection: Digital Methods To Track and Authenticate Pharmaceutical Products

This case study and associated publications (Naughton et al., 2017, 2016) paint a picture of a technically sound, planned digital solutions to address the problem presented by substandard and falsified medicines, which appear to be growing internationally, particularly as purchases increasingly take...

Bibliografski detalji
Glavni autor:	Naughton, B
Format:	Record
Izdano:	Pathways for Prosperity Commission 2018

Slični predmeti

Trade in substandard and falsified medicines
od: Hagen, N, i dr.
Izdano: (2022)

Substandard and Falsified Medicines in Myanmar
od: Mirai Sakuda, i dr.
Izdano: (2020-03-01)

Identification of substandard and falsified medicines: influence of different tolerance limits and use of authenticity inquiries
od: Hauk, C, i dr.
Izdano: (2021)

How to achieve international action on falsified and substandard medicines.
od: Attaran, A, i dr.
Izdano: (2012)

Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
od: Elizabeth Pisani, i dr.
Izdano: (2021-08-01)

The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists
od: Veronika J Wirtz, i dr.
Izdano: (2019-07-01)

Combatting substandard and falsified medicines: a view from Rwanda.
od: Agnes Binagwaho, i dr.
Izdano: (2013-01-01)

Substandard, falsified and unregistered medicines in Latin America, 2017-2018
od: Robin Rojas-Cortés
Izdano: (2020-10-01)

Quantitative screening of the pharmaceutical ingredient for the rapid identification of substandard and falsified medicines using reflectance infrared spectroscopy.
od: Graham Lawson, i dr.
Izdano: (2018-01-01)

The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
od: Cavany, S, i dr.
Izdano: (2023)

The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
od: Sean Cavany, i dr.
Izdano: (2023-10-01)

Falsified and substandard medicines trafficking: A wakeup call for the African continent
od: Yusuf Hassan Wada, i dr.
Izdano: (2022-06-01)

Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
od: Faris El-Dahiyat, i dr.
Izdano: (2021-10-01)

A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality
od: McManus, D, i dr.
Izdano: (2020)

Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines
od: Tamara Akpobolokemi, i dr.
Izdano: (2022-01-01)

A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality
od: Dominic McManus, i dr.
Izdano: (2020-08-01)

Technologies for detecting falsified and substandard drugs in low and middle-income countries.
od: Stephanie Kovacs, i dr.
Izdano: (2014-01-01)

Mobile apps for detecting falsified and substandard drugs: A systematic review.
od: Agustín Ciapponi, i dr.
Izdano: (2021-01-01)

Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
od: Zabala, GA, i dr.
Izdano: (2022)

Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
od: Paul N Newton, i dr.
Izdano: (2022-08-01)

The economic impact of substandard and falsified antimalarial medications in Nigeria.
od: Sarah M Beargie, i dr.
Izdano: (2019-01-01)

The concept of substandard (falsified and poor quality) industrial products and its types
od: K. A. Utarov, i dr.
Izdano: (2022-09-01)

The concept of substandard (falsified and poor quality) industrial products and its types
od: K. A. Utarov, i dr.
Izdano: (2022-09-01)

Substandard and falsified medical products: bibliometric analysis and mapping of scientific research
od: Waleed M. Sweileh
Izdano: (2021-09-01)

Exploring pharmacists' perspectives about substandard and falsified medical products through interviews
od: A. Persson, i dr.
Izdano: (2024-03-01)

A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
od: Tabernero, P, i dr.
Izdano: (2019)

A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
od: Tabernero, P, i dr.
Izdano: (2022)

Prevalence of substandard, falsified, unlicensed and unregistered medicine and its associated factors in Africa: a systematic review
od: Biset Asrade Mekonnen, i dr.
Izdano: (2024-12-01)

A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country
od: Daariimaa Khurelbat, i dr.
Izdano: (2020-05-01)

Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
od: Albert Petersen, i dr.
Izdano: (2017-01-01)

Prevention, Detection and Response to incidences of substandard and falsified medical products in the Member States of the Southern African Development Community
od: Stanislav Kniazkov, i dr.
Izdano: (2020-12-01)

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study.
od: Colleen R Higgins, i dr.
Izdano: (2023-01-01)

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study
od: Colleen R. Higgins, i dr.
Izdano: (2023-01-01)

Substandard and falsified antimicrobials in selected east African countries: A systematic review.
od: Addisu Afrassa Tegegne, i dr.
Izdano: (2024-01-01)

Substandard and falsified antimicrobials in selected east African countries: A systematic review
od: Addisu Afrassa Tegegne, i dr.
Izdano: (2024-01-01)

Cost savings of paper analytical devices (PADs) to detect substandard and falsified antibiotics: Kenya case study
od: Hui-Han Chen, i dr.
Izdano: (2021-03-01)

The EU Falsified Medicines Directive: key implications for dispensers
od: Naughton, B
Izdano: (2017)

Unveiling the Peril of Substandard and Falsified Medicines to Public Health and Safety in Africa: Need for All-Out War to End the Menace
od: Nafiu Aminu, i dr.
Izdano: (2017-01-01)

Establishing good authentication practice (GAP) in secondary care to protect against falsified medicines and improve patient safety
od: Naughton, B, i dr.
Izdano: (2016)

Screening for substandard and falsified medicines in Nigeria using visual inspection and GPHF-Minilab analysis: lessons learnt for future training of health workers and pharmacy personnel
od: Micha Lächele, i dr.
Izdano: (2024-12-01)